MonoMethylauristatin F (MMAF) CAS 745017-94-1

Deskripsyon pwodwi:

Non pwodwi: MonoMethylauristatin F(MMAF) CAS NO: 745017-94-1

 

Sinonim:

(2S)-2-(2R,3R)-3-metoksi-3-(2S)-1-(3R,5S)-3-metoksi-5-methyl-4-methyl-(2S)- 3-methyl-2-(2S) -3-methyl-2-(methylamino)butanoylaminobutanoylaminoheptanoylpyrrolidin-2-yl-2-methylpropanoylamino-3-phenylpropanoic asid;

Monomethyl auristatin fenilalanin;

Monomethylauristatin F;

 

Pwopriyete Chimik Fizik:

Aparans: solid poud

Egzamen : Pi gran pase oswa egal a 99.0 pousan

Density: 1.116±0.06 g/cm3 (20 degree 760 mmHg), Calc.

Solibilite dlo: Yon ti kras idrosolubl (2.8 g / L) (25 degre), Calc.

Boiling Point: 896.8±65.0 degree (Predicted)

Tanperati Depo: Sele nan sèk, Tanperati chanm

Vapour Pressure: {{0}}.0±0.3 mmHg at 25 degree

Endèks refraksyon: 1.522

 

Monomethyl auristatin F (MMAF) se yon ajan sentetik antineoplastic. Li fè pati kèk konjige eksperimantal anti-kansè-dwòg tankou vorsetuzumab mafodotin ak SGN-CD19A. Nan Non Pwopriyetè Entènasyonal pou konjige MMAF-antikò-, non mafodotin refere a MMAF ak estrikti atachman li ak antikò a.

 

Si w enterese nan pwodwi nou yo oswa si w gen nenpòt kesyon, tanpri ou lib pou kontakte nou!

 

Pwodwi anba patant yo ofri pou objektif RD sèlman. Sepandan, responsablite final la se sèlman nan achtè a.

Baj popilè: monomethylauristatin f(mmaf) cas 745017-94-1, manifaktirè, founisè, faktori, achte, nan stock

• On: MonoMethyl Auristatin E (MMAE) CAS 474645-27-7
• Pwochen: Auristatin F CAS 163768-50-1